Chemoinformaics analysis of Cyclopentanecarboxylic acid, 3-methylene-, 1,7,7-trimethylbicyclo[2.2.1]hept-2-yl ester
Molecular Weight | 262.393 | nRot | 2 |
Heavy Atom Molecular Weight | 236.185 | nRig | 15 |
Exact Molecular Weight | 262.193 | nRing | 3 |
Solubility: LogS | -5.105 | nHRing | 0 |
Solubility: LogP | 4.249 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 47.3306 |
nHD | 0 | BPOL | 28.6874 |
QED | 0.553 |
Synth | 4.739 |
Natural Product Likeliness | 2.294 |
NR-PPAR-gamma | 0.511 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.002 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.634 |
MDCK | 0.0000231 |
BBB | 0.97 |
PPB | 0.803221 |
VDSS | 1.129 |
FU | 0.254407 |
CYP1A2-inh | 0.086 |
CYP1A2-sub | 0.344 |
CYP2c19-inh | 0.142 |
CYP2c19-sub | 0.875 |
CYP2c9-inh | 0.258 |
CYP2c9-sub | 0.799 |
CYP2d6-inh | 0.007 |
CYP2d6-sub | 0.894 |
CYP3a4-inh | 0.442 |
CYP3a4-sub | 0.229 |
CL | 9.709 |
T12 | 0.056 |
hERG | 0.034 |
Ames | 0.009 |
ROA | 0.017 |
SkinSen | 0.495 |
Carcinogencity | 0.249 |
EI | 0.539 |
Respiratory | 0.869 |
NR-Aromatase | 0.061 |
Antiviral | Yes |
Prediction | 0.647539 |